iCas Citations (4)

Originally described in: A chemical-inducible CRISPR-Cas9 system for rapid control of genome editing.
Liu KI, Ramli MN, Woo CW, Wang Y, Zhao T, Zhang X, Yim GR, Chong BY, Gowher A, Chua MZ, Jung J, Lee JH, Tan MH Nat Chem Biol. 2016 Sep 12. doi: 10.1038/nchembio.2179. PubMed Journal

---

Articles Citing iCas

Articles
Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems. Liu KI, Ramli MNB, Sutrisnoh NB, Tan MH. Methods Mol Biol. 2018;1772:267-288. doi: 10.1007/978-1-4939-7795-6_15. PubMed
Genomic exploration of the targets of FOXL2 and ESR2 unveils their implication in cell migration, invasion, and adhesion. Herman L, Legois B, Todeschini AL, Veitia RA. FASEB J. 2021 Apr;35(4):e21355. doi: 10.1096/fj.202002444R. PubMed
Condensates induced by transcription inhibition localize active chromatin to nucleoli. Yasuhara T, Xing YH, Bauer NC, Lee L, Dong R, Yadav T, Soberman RJ, Rivera MN, Zou L. Mol Cell. 2022 Aug 4;82(15):2738-2753.e6. doi: 10.1016/j.molcel.2022.05.010. Epub 2022 Jun 2. PubMed
CRISPR/Cas9-mediated deletion of MADD induces cell cycle arrest and apoptosis in anaplastic thyroid cancer cells. Bakthavachalam V, Sanborn MA, Mathayan M, Salunkhe SS, Wood JM, Maienschein-Cline M, Setty S, Kabeer BSA, Rehman J, Prabhakar BS. Sci Rep. 2025 Nov 10;15(1):39264. doi: 10.1038/s41598-025-22907-1. PubMed

If you have published an article using this material, please email us at to have your article added to this page.